Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

Proactive news snapshot: Tower Resources, MySQUAR, Kore Potash …

A glance at some of the day's highlights from the Proactive Investors newswire

Shares in Tower Resources PLC (LON:TRP) jumped after it unveiled a reserves report for its Thali licence, offshore Cameroon. The AIM-listed oiler said the report had identified gross mean contingent resources of 18mln barrels (MMbbl) of oil across the proven Njonji-1 and Njonji-2 fault blocks with low/best/high estimates of 5/15/34 MMbbls respectively and a development contingency probability of 80% on first phase and 70% on second phase.

MySQUAR Limited (LON:MYSQ) shares rose after the Myanmar-language social media, entertainment and payments platform revealed that, on 30th October 2018, MyPay Limited disposed of its remaining holding and so is no longer a shareholder in the company.

Kore Potash PLC (LON:KP2) shares gained after it confirmed that, further to its announcement on 30 October, the French Consortium of Engineering Companies have delivered the final volume of the Definitive Feasibility Study (DFS) documentation for the Sintoukola Potash Project (Kola), located within the Republic of Congo. The company said it therefore has a complete set of DFS documents and has commenced its review of this study and will update shareholders further when this is complete and the DFS is finalised.

Stobart Group Ltd (LON:STOB) said its regional airline, Stobart Air, has secured a deal to provide new aircraft, crew, maintenance, and insurance (ACMI) services to BA CityFlyer, the short-haul arm of British Airways.

Coinsilium Group Limited (AQSE:COIN) has signed an advisory partnership agreement with LC LITE, a firm developing a letter of credit platform, to advise on a token generation event (TGE). The blockchain venture and advisory firm said it would support LC in the preparation and execution of the TGE, with chief executive Eddy Travia to join the advisory board of LC.

The past year has been an “exciting period” for Greatland Gold PLC (LON:GGP), the AIM-listed precious and base metals explorer. Greatland has four projects in Western Australia – Paterson, Ernest Giles, Panorama and Bromus – as well as Firetower and Warrentinna in Tasmania.

Rose Petroleum PLC (LON:ROSE) is to drill the GV 22-1 well at its Paradox acreage in Utah “as soon as possible” after being given the green light from US authorities.

NetScientific PLC’s (LON:NSCI) portfolio company, Vortex BioSciences, has secured a global manufacturing agreement with German firm STRATEC Consumables GmbH to scale up production of its VTX-1 liquid biopsy platform.

AFC Energy PLC (LON:AFC) has updated on the progress with its first commercial order. It said it has conducted “initial engineering and supply chain preparedness work” in advance of finalising terms for the delivery of fuel cells to customer Southern Oil’s Gladstone Refinery in Queensland, Australia.

ANGLE PLC (LON:AGL) (OTCQX:ANPCY), a world-leading liquid biopsy company, has announced the appointment of Dr Jan Groen as a non-executive director with immediate effect. The firm noted that Groen has extensive board and executive level experience in cancer diagnostics, and he is currently president and CEO of MDxHealth, a Euronext listed molecular diagnostic company.

Metal Tiger PLC (LON:MTR) said that, further to its announcement on 18 July, it now expects that completion of the sale of the T3 project and the creation of the new exploration joint venture with MOD Resources will occur by mid-November, with the only outstanding condition precedent for completion being the demerger itself. The company also announced the appointment of Strand Hanson as its nominated adviser with immediate effect, and said SI Capital is the company’s sole broker with immediate effect.

MySQUAR Limited announced that on 30th October 2018 MyPay Limited disposed of its remaining holding and so it is no longer a shareholder in the company.

Midatech Pharma Plc (LON:MTPH) (NASDAQ:MTP), the R&D company focused on delivering innovative oncology and rare disease products to patients, announced that the proposed sale of Midatech Pharma US Inc to Kanwa Holdings, LP has now completed.

PCF Group Plc (LON:PCF), the parent of specialist bank PCF Bank, announced that its acquisition of Azule Limited, previously announced on 8 October 2018, has now completed following receipt of Financial Conduct Authority approval.

Tharisa plc (LON:THA), the dual-listed platinum group metals and chrome co-producer, has announced the appointment of Berenberg as the company's joint corporate broker with immediate effect. The group said Berenberg will work alongside the company's existing UK joint corporate brokers, Peel Hunt LLP and BMO Capital Markets.

Active Energy Group PLC (LON:AEG) confirmed that Richard Spinks has now formally stepped down from the firm’s board to focus on his other business interests including the group's subsidiary business, Timberlands International Ltd. The company noted that its board will now temporarily comprise of only two directors and said, as such, its management team are currently evaluating potential new directors with further announcements to be made in due course.

LIVE Company PLC (LON:LVCG) said it has held discussions with candidates on the appointment of a further independent non-executive director who would add public company experience to the board, with further details to be notified at the appropriate time. The revelation came as the company confirmed the appointments of Trudy Norris-Grey as an independent non-executive director and Simon Horgan as non-executive director with effect from today. The group also announced a number of senior management appointments in connection with the business combination and integration subsequent to its acquisition of Bright Bricks, with Andy Smith stepping into the role of executive chairman at Bright Bricks. Smith would continue is his role as chief strategic officer on the Board of Live Company as well.

LNS, a shareholder with more than 10% of chrome producer Afarak Group plc (LON:AFRK), has clarified its position ahead of Afarak’s upcoming extraordinary meeting. LNS has argued for some time that because of liquidity constraints, particularly in the local Helsinki market, where Afarak is based, the company should offer to buy out its shareholders.

Obtala Limited (LON:OBT) said it is in talks with several nominated advisors after Northland Capital Partners informed the company that it has voluntarily agreed to relinquish that status due to its proposed merger with SP Angel Corporate Finance. Obtala noted that Northland will be removed from the register of nominated advisers with effect from 7am on 1 February 2019 and the firm said it is confident that a suitable replacement will be appointed by that date. If the company has failed to appoint a replacement nominated adviser by 4 March 2019, however, its AIM listing will be cancelled.

Sunrise Resources Plc (LON:SRES) also said it has already initiated talks with a number of parties to appoint a new nomad to replace Northland Capital and is confident that a suitable replacement will be appointed by the required date. The group said a further announcement will be made in due course.

PhotonStar LED Group PLC (LON:PSL) and ImmuPharma PLC (LON:IMM) also spotlighted the Northland Capital news with both noting that if they have failed to appoint a new nominated adviser by 1 February 2019 their shares will be suspended on AIM and then cancelled on 4 March 2019 if there is still no replacement.

Summit Therapeutics PLC (LON:SUMM) (NASDAQ:SMMT), a leader in new mechanism antibiotic innovation, has said it recognises the start of C. difficile Awareness Month, which highlights the common, but largely unknown C. difficile infection (CDI) throughout November. As part of CDI Awareness Month, the group added, it is presenting on its precision antibiotic ridinilazole and the Phase 3 clinical trial plans for it at the 6th Annual International C. diff Conference and Health Expo taking place 8-9 November 2018 in Philadelphia.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK